» Articles » PMID: 11736946

Pruritus in Polycythaemia Vera: Prevalence, Laboratory Correlates and Management

Overview
Journal Br J Haematol
Specialty Hematology
Date 2001 Dec 12
PMID 11736946
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

In a retrospective cohort, 192 (48%) out of 397 patients with polycythaemia vera had a documented history of pruritus. At diagnosis, the presence of pruritus was significantly associated with a lower mean corpuscular volume and a higher leucocyte count. Among 66 patients with documentation of treatment for pruritus, 389 'patient visits' were reviewed, revealing a significant correlation between active pruritus and low mean corpuscular volume, but not platelet, leucocyte or basophil count. Paroxetine and hydroxyzine were rated by patients to be the most effective drugs in controlling pruritus. These observations suggest a pathogenetic role for both iron deficiency and biogenic amines in polycythaemia vera-associated pruritus.

Citing Articles

Practical guide for the diagnosis and treatment of localized and generalized cutaneous pruritus (chronic itch with no underlying pruritic dermatosis).

Hashimoto T, Okuno S J Dermatol. 2024; 52(2):204-220.

PMID: 39663861 PMC: 11807371. DOI: 10.1111/1346-8138.17565.


The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells.

Poto R, Cristinziano L, Criscuolo G, Strisciuglio C, Palestra F, Lagnese G Front Immunol. 2024; 15:1443704.

PMID: 39188724 PMC: 11345246. DOI: 10.3389/fimmu.2024.1443704.


Upadacitinib as a treatment for chronic pruritus secondary to polycythemia vera after failure with dupilumab.

Wachuku C, Barrera T, Jackson T, Sow Y, Mollanazar N, Taylor S JAAD Case Rep. 2023; 35:87-89.

PMID: 37223110 PMC: 10201202. DOI: 10.1016/j.jdcr.2023.02.024.


The potential action of SSRIs in the treatment of skin diseases including atopic dermatitis and slow-healing wounds.

Kiecka A, Szczepanik M Pharmacol Rep. 2022; 74(5):947-955.

PMID: 36203121 PMC: 9584846. DOI: 10.1007/s43440-022-00423-7.


IL-31: State of the Art for an Inflammation-Oriented Interleukin.

Borgia F, Custurone P, Li Pomi F, Cordiano R, Alessandrello C, Gangemi S Int J Mol Sci. 2022; 23(12).

PMID: 35742951 PMC: 9223565. DOI: 10.3390/ijms23126507.